# Vor Biopharma Inc.: Form 8-K, filed Jun 26, 2025

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: 8-K
- Filed: 2025-06-26
- Accepted by EDGAR: Jun 25, 2025, 21:18 ET
- Period: 2025-06-25
- Accession: 0001193125-25-147339
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525147339/d27026d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000119312525147339/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000119312525147339/d27026d8k.htm

Filed Jun 26, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-147339. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.